Recently we reported that TM4SF5 activates STAT3 for the pathological progression to NASH-associated with fibrosis via hepatic inflammation-concomitant SOCS1/3 down-regulation [24]. The gene discussed is STAT3; the disease is metabolic dysfunction-associated steatohepatitis.